Back to Sites St. Mary's CRS Site Number 30303 Address St Mary's CRS St Mary's Clinic Ingwe Road Chitungwiza, Zimbabwe IMPAACT Members at this Site Lynda Stranix-Chibanda Clinical/Site Coordinator Suzen Maonera CRS Coordinator Tsungai Chipato CRS Leader Rose A. Kambarami CRS Leader Betty Jowa CRS Staff Zvavahera M. Chirenje CTU Principal Investigator Bola Adedeji DAIDS PO Marshall W. Munjoma Laboratory Manager/Supervisor Simbarashe Mujuru Laboratory Technician/Technologist Bangani Kusakara Medical Officer Vongai Margret Chanaiwa Pharmacist Mercy Tapiwa Mutambanengwe Pharmacist of Record Netsai Mudzonga QA/QC Coordinator Peter Kanda Quality Assurance Studies at this Site P1078: TB APPRISE: TB Ante vs. Postpartum Prevention with INH in HIV Seropositive mothers and their Exposed infants DAIDS Number 10732 Research Area Tuberculosis Study Status Participants Off Study and Primary Analysis Completed Locality Non-US P1084s: Maternal Infant TDF Toxicity Safety DAIDS Number 10790 Research Area Complications & Comorbidities Study Status Closed to Follow Up Locality Non-US 1077BF: PROMISE 1077BF DAIDS Number 10777 Research Area Prevention Study Status Participants Off Study and Primary Analysis Completed Locality Non-US P1115: Very Early Intensive Tx on HIV-Infected Infants DAIDS Number 11954 Research Area Cure Study Status Enrolling Locality US & Non-US IMPAACT 2009 : Pharmacokinetics, Feasibility, Acceptability, and Safety of Oral Pre-Exposure Prophylaxis for Primary HIV Prevention during Pregnancy and Postpartum in Adolescents and Young Women and their Infants DAIDS Number 30020 Research Area Prevention Study Status Enrolling Locality Non-US IMPAACT 2010: VESTED DAIDS Number 30129 Research Area Treatment Study Status Closed to Follow Up Locality US & Non-US IMPAACT 2016: Evaluating a Group-Based Intervention to Improve Mental Health and ART Adherence Among Youth Living with HIV in Low Resource Settings DAIDS Number 38506 Research Area Complications & Comorbidities Study Status Open to Accrual Locality Non-US IMPAACT 2026: Pharmacokinetic Properties of Antiretroviral and Anti-Tuberculosis Drugs During Pregnancy and Postpartum DAIDS Number 38609 Research Area Treatment Study Status Pending Locality US & Non-US IMPAACT 2028: Long-Term Clinical, Immunologic, and Virologic Profiles of Children who Received Early Treatment for HIV DAIDS Number 38693 Research Area Cure Study Status Pending Locality US & Non-US
P1078: TB APPRISE: TB Ante vs. Postpartum Prevention with INH in HIV Seropositive mothers and their Exposed infants DAIDS Number 10732 Research Area Tuberculosis Study Status Participants Off Study and Primary Analysis Completed Locality Non-US
P1084s: Maternal Infant TDF Toxicity Safety DAIDS Number 10790 Research Area Complications & Comorbidities Study Status Closed to Follow Up Locality Non-US
1077BF: PROMISE 1077BF DAIDS Number 10777 Research Area Prevention Study Status Participants Off Study and Primary Analysis Completed Locality Non-US
P1115: Very Early Intensive Tx on HIV-Infected Infants DAIDS Number 11954 Research Area Cure Study Status Enrolling Locality US & Non-US
IMPAACT 2009 : Pharmacokinetics, Feasibility, Acceptability, and Safety of Oral Pre-Exposure Prophylaxis for Primary HIV Prevention during Pregnancy and Postpartum in Adolescents and Young Women and their Infants DAIDS Number 30020 Research Area Prevention Study Status Enrolling Locality Non-US
IMPAACT 2010: VESTED DAIDS Number 30129 Research Area Treatment Study Status Closed to Follow Up Locality US & Non-US
IMPAACT 2016: Evaluating a Group-Based Intervention to Improve Mental Health and ART Adherence Among Youth Living with HIV in Low Resource Settings DAIDS Number 38506 Research Area Complications & Comorbidities Study Status Open to Accrual Locality Non-US
IMPAACT 2026: Pharmacokinetic Properties of Antiretroviral and Anti-Tuberculosis Drugs During Pregnancy and Postpartum DAIDS Number 38609 Research Area Treatment Study Status Pending Locality US & Non-US
IMPAACT 2028: Long-Term Clinical, Immunologic, and Virologic Profiles of Children who Received Early Treatment for HIV DAIDS Number 38693 Research Area Cure Study Status Pending Locality US & Non-US